HomeCompareBIEL vs EQR

BIEL vs EQR: Dividend Comparison 2026

BIEL yields 500000.00% · EQR yields 4.73%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 BIEL wins by $4.663521010693878e+33M in total portfolio value
10 years
BIEL
BIEL
● Live price
500000.00%
Share price
$0.00
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$4.663521010693878e+33M
Annual income
$4,661,686,961,926,996,000,000,000,000,000,000,000,000.00
Full BIEL calculator →
EQR
EQR
● Live price
4.73%
Share price
$58.58
Annual div
$2.77
5Y div CAGR
15.8%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$40.5K
Annual income
$3,819.61
Full EQR calculator →

Portfolio growth — BIEL vs EQR

📍 BIEL pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodBIELEQR
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, BIEL + EQR cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
BIEL pays
EQR pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

BIEL
Annual income on $10K today (after 15% tax)
$42,500,000.00/yr
After 10yr DRIP, annual income (after tax)
$3,962,433,917,637,946,000,000,000,000,000,000,000,000.00/yr
EQR
Annual income on $10K today (after 15% tax)
$401.93/yr
After 10yr DRIP, annual income (after tax)
$3,246.67/yr
At 15% tax rate, BIEL beats the other by $3,962,433,917,637,946,000,000,000,000,000,000,000,000.00/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of BIEL + EQR for your $10,000?

BIEL: 50%EQR: 50%
100% EQR50/50100% BIEL
Portfolio after 10yr
$2.331760505346939e+33M
Annual income
$2,330,843,480,963,498,000,000,000,000,000,000,000,000.00/yr
Blended yield
99.96%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on EQR right now

BIEL
No analyst data
EQR
Analyst Ratings
16
Buy
28
Hold
2
Sell
Consensus: Hold
Price Target
$70.35
+20.1% upside vs current
Range: $63.00 — $78.50
Altman Z
1.8
Piotroski
7/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

BIEL buys
0
EQR buys
0
No recent congressional trades found for BIEL or EQR in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricBIELEQR
Forward yield500000.00%4.73%
Annual dividend / share$2.00$2.77
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%15.8%
Portfolio after 10y$4.663521010693878e+33M$40.5K
Annual income after 10y$4,661,686,961,926,996,000,000,000,000,000,000,000,000.00$3,819.61
Total dividends collected$4.6634009849658873e+33M$16.9K
Payment frequencyquarterlyquarterly
SectorStockREIT

Year-by-year: BIEL vs EQR ($10,000, DRIP)

YearBIEL PortfolioBIEL Income/yrEQR PortfolioEQR Income/yrGap
1← crossover$50,010,700$50,000,000.00$11,248$547.57+$50.00MBIEL
2$233,748,371,262$233,694,859,813.08$12,701$666.53+$233748.36MBIEL
3$1,021,074,511,412,696$1,020,824,400,655,446.10$14,405$814.59+$1021074511.40MBIEL
4$4,168,597,328,794,951,700$4,167,504,779,067,739,000.00$16,413$999.84+$4168597328794.94MBIEL
5$15,905,475,114,600,665,000,000$15,901,014,715,458,854,000,000.00$18,795$1,232.92+$15905475114600664.00MBIEL
6$56,718,938,532,531,060,000,000,000$56,701,919,674,158,435,000,000,000.00$21,639$1,527.95+$56718938532531060736.00MBIEL
7$189,031,807,435,623,860,000,000,000,000$188,971,118,171,394,040,000,000,000,000.00$25,057$1,903.80+$1.8903180743562385e+23MBIEL
8$588,799,810,476,518,260,000,000,000,000,000$588,597,546,442,562,100,000,000,000,000,000.00$29,197$2,385.87+$5.8879981047651824e+26MBIEL
9$1,714,064,268,114,722,600,000,000,000,000,000,000$1,713,434,252,317,512,700,000,000,000,000,000,000.00$34,250$3,008.70+$1.7140642681147225e+30MBIEL
10$4,663,521,010,693,878,300,000,000,000,000,000,000,000$4,661,686,961,926,996,000,000,000,000,000,000,000,000.00$40,467$3,819.61+$4.663521010693878e+33MBIEL

BIEL vs EQR: Complete Analysis 2026

BIELStock

BioElectronics Corporation, an electroceutical company, engages in the development and sale of wearable, neuromodulation devices to mitigate neurological diseases and enhance quality of life worldwide. Its products include ActiPatch, a musculoskeletal pain therapy; Allay, a menstrual pain therapy; and Smart Insole, a heel pain therapy. The company also offers RecoveryRx, a medical device that provides pain management therapy for medical professionals; and HealFast, a drug-free therapy for horses, cats, and dogs that reduces swelling and pain, as well as heals muscle and tendon injuries, sores, and incisions. It sells its products to wholesale distributors, hospitals and clinics, and consumers. The company was incorporated in 2000 and is headquartered in Frederick, Maryland.

Full BIEL Calculator →

EQRREIT

Equity Residential is committed to creating communities where people thrive. The Company, a member of the S&P 500, is focused on the acquisition, development and management of residential properties located in and around dynamic cities that attract high quality long-term renters. Equity Residential owns or has investments in 305 properties consisting of 78,568 apartment units, located in Boston, New York, Washington, D.C., Seattle, San Francisco, Southern California and Denver.

Full EQR Calculator →
📬

Get this BIEL vs EQR comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

BIEL vs SCHDBIEL vs JEPIBIEL vs OBIEL vs KOBIEL vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.